Arbutus Biopharma Corporation
ABUS
$2.90
-$0.05-1.70%
Rating Factors
Growth Index
Efficiency Index
--
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/2/2023
-
Ticker Report
2/1/2023
-
Tickeron - Stocks
1/27/2023
-
Globe Newswire
1/22/2023
-
Zolmax
1/21/2023
-
Ticker Report
1/12/2023
-
Zacks Investment Research
1/11/2023
-
Ticker Report
1/11/2023
-
Zolmax
1/5/2023
-
ETF Channel
1/5/2023
-
Globe Newswire
12/21/2022
-
Simply Wall St
12/19/2022
-
Ticker Report
12/13/2022
-
Globe Newswire
12/9/2022
-
Ticker Report
12/9/2022
-
Ticker Report
12/6/2022
-
Zolmax
12/6/2022
-
Ticker Report
12/5/2022
-
Zolmax
12/1/2022
-
Ticker Report
12/1/2022
-
ETF Channel
11/26/2022
-
Zolmax
11/16/2022
-
Ticker Report
11/16/2022
-
Ticker Report
11/15/2022
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 9, 2022
Period Date
Friday, September 30, 2022
Next Filing
Beginning of March (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
267 469 0914
Address
701 Veterans Circle
Warminster, PA 18974
Warminster, PA 18974
Country
Year Founded
--
Business Description
Sector
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States...
more
